Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abcam Plc (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12407
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products are used by life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.

Abcam Plc (ABC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10
Abcam Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Abcam Plc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
AxioMx Raises US$2 Million In Second Round Of Venture Financing 12
AxioMx Raises US$2 Million In Venture Financing 13
AxioMx Raises Additional US$0.5 Million In Venture Financing 14
Partnerships 15
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Licensing Agreements 16
Abcam Enters into Licensing Agreement with Roche 16
Abcam Enters into Licensing Agreement with Horizon Discovery 17
Children’s Cancer Institute Enters into Licensing Agreement with Abcam 18
TGR BioSciences Enters Into Licensing Agreement With Abcam 19
Abcam Enters Into Licensing Agreement With Pfizer 20
Equity Offering 21
Abcam Completes Private Placement Of Shares For US$77 Million 21
Acquisition 22
Abcam Acquires AxioMx 22
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 23
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 24
Abcam Plc – Key Competitors 25
Abcam Plc – Key Employees 26
Abcam Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Sep 10, 2018: Abcam: Preliminary results 2018 29
Mar 05, 2018: Abcam: Interim results for the six months ended 31 December 2017 31
Sep 11, 2017: Abcam: Double-digit earnings growth enabling investment for sustained future growth 32
Corporate Communications 33
Oct 30, 2018: Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development 33
Jun 18, 2018: Abcam Appoints Peter Allen As Chairman 34
Nov 15, 2017: ABCAM: Result of AGM and Directorate Change 35
Oct 11, 2017: Abcam: Directorate Change – Chairman 36
Product News 37
Feb 06, 2018: Introducing FirePlex-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples 37
Other Significant Developments 38
Jul 27, 2017: Abcam: Pre-Close Period Update 38
Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Abcam Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10
Abcam Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AxioMx Raises US$2 Million In Second Round Of Venture Financing 12
AxioMx Raises US$2 Million In Venture Financing 13
AxioMx Raises Additional US$0.5 Million In Venture Financing 14
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Abcam Enters into Licensing Agreement with Roche 16
Abcam Enters into Licensing Agreement with Horizon Discovery 17
Children’s Cancer Institute Enters into Licensing Agreement with Abcam 18
TGR BioSciences Enters Into Licensing Agreement With Abcam 19
Abcam Enters Into Licensing Agreement With Pfizer 20
Abcam Completes Private Placement Of Shares For US$77 Million 21
Abcam Acquires AxioMx 22
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 23
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 24
Abcam Plc, Key Competitors 25
Abcam Plc, Key Employees 26
Abcam Plc, Subsidiaries 27

List of Figures
Abcam Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ModusLink Global Solutions, Inc. (MLNK):企業の財務・戦略的SWOT分析
    ModusLink Global Solutions, Inc. (MLNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Australia and New Zealand Banking Group Ltd:企業の戦略・SWOT・財務情報
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • MediaValet Inc.:戦略・SWOT・企業財務分析
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Petropavlovsk PLC:企業の戦略・SWOT・財務情報
    Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report Summary Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Casey’s General Stores, Inc.:企業の戦略・SWOT・財務分析
    Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Harley-Davidson, Inc.:企業の戦略・SWOT・財務情報
    Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nordex SE (NDX1)-エネルギー分野:企業M&A・提携分析
    Summary Nordex SE (Nordex) is a manufacturer of wind turbines. Along with its subsidiaries, the company conducts the development, production, servicing and marketing of wind power systems. The service portfolio related to technical planning of wind farm systems ranges from the identification of suit …
  • Mckesson Europe AG (CLS1):製薬・医療:M&Aディール及び事業提携情報
    Summary Mckesson Europe AG (Mckesson Europe), formerly known as Celesio AG, is a provider of logistics and services to healthcare and pharmaceutical sectors across Europe. The company is involved in providing distribution solution to its wholesale, institutional and retail customers and delivering p …
  • ImmunoCellular Therapeutics Ltd (IMUC):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Haverty Furniture Companies, Inc. (HVT):企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Statkraft AS:電力:M&Aディール及び事業提携情報
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and supplies district heating. It generates power from hydro, wind, gas, solar and bio-power sources. The company develops hydroelectric power plants in emerging markets outside Europe. Stat …
  • Eneva SA (ENEV3):石油・ガス:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • French National Institute of Health and Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in therapeutic areas such as neurosciences, sciences, neurology, psychiatry, cancer, genetics, can …
  • GOJO Industries Inc:企業の戦略・SWOT・財務情報
    GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report Summary GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides seaborne transportation, tanker shipping, proactive management, fleet composition and ship management services. It offers ship management services which includes technical servi …
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆